Ascribe Bioscience

Developer of natural crop protection products using soil microbiome molecules

placeIthaca, New York, United States calendar_todayFounded 2017 groups8 employees language ascribebio.com

Registered entities

Innovation

14 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 128 times.

YearFilings
20221
20236
20247
202513
20267

Social engagement

Social engagement: 2.8K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include The Yield Lab, Acre Venture Partners, Source Agriculture, Corteva Agriscience.

Investor typeCountShare
Venture capital436%
Private equity19%
Other / undisclosed655%

Recent activity

4 Jun 2026
Partnership
Syngenta
20 May 2026
Product launch
Phytalix®
5 Mar 2026
Partnership
Corteva Agriscience
Coming soon